Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-24-035167
Filing Date
2024-11-14
Accepted
2024-11-14 12:21:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 nrxp20241112_s1.htm S-1 341524
2 EXHIBIT 23.1 ex_747113.htm EX-23.1 2724
3 EX-FILING FEES ex_747108.htm EX-FILING FEES 48495
4 image1.jpg GRAPHIC 6390
5 image2.jpg GRAPHIC 8082
  Complete submission text file 0001437749-24-035167.txt   414043
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283220 | Film No.: 241459314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)